What is Kailera Therapeutics 's restricted cash?

Kailera Therapeutics (KLRA) reported restricted cash of $761.00K in Q1 2026.

What does restricted cash mean?

Cash that is legally tied up and cannot be used for day-to-day operations.

Restricted Cash

Kailera Therapeutics Restricted Cash remained flat by 0.0% to $761.00K in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

CategoryLiquidity

SignalContext dependent

VolatilityStable

First reportedQ4 2025

Last reportedQ1 2026May 26, 2026

How to read this metric

An increase may signal higher debt service requirements or increased collateral obligations, while a decrease may indicate the release of restricted funds.

Detailed definition

Cash balances that are legally or contractually set aside for specific purposes, such as debt service reserves, collater...

Peer comparison

Common in capital-intensive industries like energy where project financing requires specific reserve accounts.

Metric ID: restricted_cash

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$761.00K	$761.00K
QoQ Change	—	+0.0%

Range$761.00K – $761.00K

Restricted Cash at Other Companies

United Airlines HoldingsUAL View metric

Ares Management CorporationARES View metric

Medline, Inc. MDLN View metric

KKR & Co.KKR View metric

BKBK View metric

Frequently Asked Questions

What is Kailera Therapeutics 's restricted cash?: Kailera Therapeutics (KLRA) reported restricted cash of $761.00K in Q1 2026.
What does restricted cash mean?: Cash that is legally tied up and cannot be used for day-to-day operations.